Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc PfizerfiledCriticalInc Pfizer
Priority to HN2002000128ApriorityCriticalpatent/HN2002000128A/en
Publication of HN2002000128ApublicationCriticalpatent/HN2002000128A/en
LA PRESENTE INVENCIÓN SE REFIERE A UNA COMBINACION PARA INHALAR DE UN AGONISTA SELECTIVO DEL RECEPTOR A2A DE ADENOSINA Y UN AGENTE ANTICOLINERGICO, CON LA CONDICIÓN DE QUE EL AGENTE ANTICOLINERGICO NO SEA UNA SAL DE TIOTROPIO.THE PRESENT INVENTION REFERS TO A COMBINATION FOR INHALING A SELECTIVE AGONIST OF ADENOSINE A2A RECEPTOR AND AN ANTICHOLINERGIC AGENT, WITH THE CONDITION THAT THE ANTICHOLINERGIC AGENT IS NOT A TIOTROPE SALT.
HN2002000128A2002-05-242002-05-24
AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS.
HN2002000128A
(en)